The History of Terrorism
Preview
Open in TheBrain
Links
RBM Partnership to End Malaria Partners
1639-Today Harvard University
Peter Bach
Attachments
wikipedia
Parents
1639-Today Harvard University
1884-Today Memorial Sloan Kettering Cancer Center (MSK or MSKCC)
American medical researchers
Cancer researchers
Lung cancer specialists
Medicare
Rockefeller and cancer links
University of Chicago Harris School of Public Policy
University of Minnesota Medical School
Children
"The core understanding of clinical research participation and clinical research conduct is we run the trial rigorously to provide the most accurate information about...
2012 In 2012, Bach, who is a frequent critic of pharmaceutical pricing in cancer, co-authored an opinion piece in the New York Times outlining Memorial Sloan Kettering's decision not to offer a new cancer drug, Zaltrap, to its patients due to the drug's...
2020 STAT - Inside the NIH's controversial decision to stop its big remdesivir study
Bach chronicled his wife Ruth's treatment for early breast cancer in a series of articles for the New York Times, and then wrote about her death from the disease in a piece for New York Magazine.
Peter Bach, the director of the Center for Health Policy and Outcomes at Memorial Sloan Kettering Cancer Center, agreed with Nissen.
The New York Times piece by Bach was discussed in a 60 Minutes segment highlighting the rising cost of cancer drugs.[5] Bach was seen as influential in the eventual lowering of Zaltrap's price by the manufacturer Sanofi.